Objective: To compare operative outcomes of robot-assisted prostatectomy (RARP) in obese and non-obese patients with prostate cancer.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Materials and Methods: A literature search of MEDLINE, EMBASE, Google Scholar and the Cochrane Library was performed up to March 2014. All studies assessing operative outcomes of RARP in obese and non-obese patients were included. Outcome measures were perioperative and functional results, including operating time, estimated blood loss (EBL), complications, length of hospital stay (LOS), positive surgical margins (PSM) and recovery of continence and potency. Pooled odds ratios (OR) and weighted mean differences (WMD) with 95% conﬁdence intervals (CI) were calculated using ﬁxed-effects or random-effects model. Subgroup analysis was performed for institutions with greater experience of RARP in obese cases.
Results: Thirteen observational studies from 12 study population were included for 1821 obese patients compared with 4801 non-obese patients. Operating time (P = 0.0001; WMD: 24.28; 95%CI, 11.93-36.64) and EBL (P = 0.003; WMD: 38.28; 95%CI, 13.45-63.11) were significantly increased in obese patients compared with non-obese counterparts. There was no significant difference in complications, LOS or PSM rates. Subgroup analysis for studies involving ≥100 obese cases showed consistent results, but the increases in operating time (9.8 min; 95%CI, 1.7-18 min) and EBL (14 ml; 95%CI, 5.0-23 ml) were much lower compared with the original analysis. As for functional outcomes, obese patients showed significantly higher probabilities of incontinence (P = 0.003; OR: 1.41; 95%CI, 1.13-1.77) and impotency (P = 0.02; OR: 1.29; 95%CI, 1.03-1.61) at 1 year.
Conclusions: Perioperative outcomes of RARP in obese patients are comparable with those in non-obese patients, except for significant but small increases in operating time and EBL. Surgeons should initiate RARP procedures in obese cases after overcoming the learning curve. Further studies should be performed to evaluate the functional outcomes for obese patients undergoing RARP.
Xu T, Wang X, Xia L, Zhang X, Qin L, Zhong S, Shen Z. Are you the author?
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Department of Urology, Shanghai, China.
Reference: J Endourol. 2014 Sep 1. Epub ahead of print.